Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN). (Q34728110)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Ufuk M Abacioglu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

9

David Azria

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Hadassah Goldberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Roxolyana Abdah-Bortnyak

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Mariana Steiner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Ferah Yildiz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Amichay Meirovitz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Salvador Villà

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Philip M P Poortmans

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Jamal Zidan

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Mahmut Ozsahin

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Douglas G Gold

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Amnon Amit

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Ofer Lavie

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

I Lale Atahan

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Abraham Kuten

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Rare Cancer Network

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

21 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

298-305

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

Endometrial cancer: the management of high-risk disease

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

Uterine papillary serous carcinoma: patterns of metastatic spread

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

Uterine papillary serous carcinoma: what have we learned over the past quarter century?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

Surgical management of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

Uterine papillary serous carcinoma: evaluation of multimodality treatment with abdominopelvic radiotherapy and chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

Outcome and pattern of failure in pathologic stage I–II papillary serous carcinoma of the endometrium: Implications for adjuvant radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

The role of abdominal-pelvic radiotherapy in the management of uterine papillary serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

Early stage uterine papillary serous carcinoma of the endometrium: effect of adjuvant whole abdominal radiotherapy and pathologic parameters on outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

Papillary serous carcinoma--a less radio-sensitive subtype of endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

HER-2/neu overexpression in uterine papillary serous cancers and its possible therapeutic implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.037

10.1016/J.YGYNO.2007.10.037

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18096209%20AND%20SRC:MED&resulttype=core&format=json

release_kdw6dfazo5gnbe4q2wkuzju724

30 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kdw6dfazo5gnbe4q2wkuzju724

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference